Resverlogix Corp. (TSE:RVX – Get Free Report) hit a new 52-week low during mid-day trading on Wednesday. The stock traded as low as C$0.07 and last traded at C$0.07, with a volume of 3,000 shares traded. The stock had previously closed at C$0.07.
Resverlogix Trading Down 6.3%
The business has a 50 day moving average price of C$0.09 and a 200 day moving average price of C$0.10. The company has a current ratio of 0.04, a quick ratio of 0.04 and a debt-to-equity ratio of -82.47. The company has a market capitalization of C$25.82 million, a P/E ratio of -1.88 and a beta of -0.11.
Resverlogix Company Profile
Founded in 2001, Resverlogix is a Calgary based late-stage biotechnology company, and a world leader in epigenetics, with the goal of developing first-in-class therapies for the benefit of patients with chronic disease. Resverlogix is developing a new class of epigenetic therapies designed to regulate the expression of disease-causing genes. We aim to improve patients’ lives by restoring biological functions – altered by serious illnesses such as cardiovascular disease – back to a healthier state.
Read More
- Five stocks we like better than Resverlogix
- Amazon’s Record Margins Couldn’t Stop the Sell-Off—Here’s Why
- DoorDash’s $17 Billion Bet on Instacart Faces a Long Regulatory Road Ahead
- FTC Puts A Wrinkle In the Cintas and UniFirst Merger
- Breaching the Valuation: The Real Reason Fortinet Dropped
Receive News & Ratings for Resverlogix Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Resverlogix and related companies with MarketBeat.com's FREE daily email newsletter.
